What's more, most TDP1 substrates are formed by clinically active (chemo-)therapeutics and endogenous reactive oxygen species whose levels are elevated in cancer cells [3, 4, 11, 13, 14, 16–20, 22, 23, 25–27, 39–45]. The gene discussed is TDP1; the disease is cancer.